Literature DB >> 17692749

Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity.

Craig S Broberg1, Masuo Ujita, Sanjay Prasad, Wei Li, Michael Rubens, Bridget E Bax, Simon J Davidson, Beatriz Bouzas, J Simon R Gibbs, John Burman, Michael A Gatzoulis.   

Abstract

OBJECTIVES: This study sought to determine what factors are associated with pulmonary artery thrombi in Eisenmenger patients.
BACKGROUND: Pulmonary artery thrombosis is common in Eisenmenger syndrome, although its underlying pathophysiology is poorly understood.
METHODS: Adult patients with Eisenmenger syndrome underwent computed tomography pulmonary angiography, cardiac magnetic resonance imaging, and echocardiography. Measurement of ventricular function, pulmonary artery size, and pulmonary artery blood flow were obtained. Hypercoagulability screening and platelet function assays were performed.
RESULTS: Of 55 consecutive patients, 11 (20%) had a detectable thrombus. These patients were older (p = 0.032), but did not differ in oxygen saturation, hemoglobin, or hematocrit from those without thrombus. Right ventricular ejection fraction by magnetic resonance imaging was lower in those with thrombus (0.41 +/- 0.15 vs. 0.53 +/- 0.13, p = 0.017), as was left ventricular ejection fraction (0.48 +/- 0.12 vs. 0.60 +/- 0.09, p = 0.002), a finding corroborated by tissue Doppler and increased brain natriuretic peptide. Those with thrombus also had a larger main pulmonary artery diameter (48 +/- 14 mm vs. 38 +/- 9 mm, p = 0.007) and a lower peak systolic velocity in the pulmonary artery (p = 0.003). There were no differences in clotting factors, platelet function, or bronchial arteries between groups. Logistic regression showed pulmonary artery velocity to be independently associated with thrombosis.
CONCLUSIONS: Pulmonary arterial thrombosis among adults with Eisenmenger syndrome is common and relates to older age, biventricular dysfunction, and slow pulmonary artery blood flow rather than degree of cyanosis or coagulation abnormalities. Further work to define treatment efficacy is needed.

Entities:  

Mesh:

Year:  2007        PMID: 17692749     DOI: 10.1016/j.jacc.2007.04.056

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

Review 1.  Management of acute heart failure in adult patients with congenital heart disease.

Authors:  Alexander Van De Bruaene; Lukas Meier; Walter Droogne; Pieter De Meester; Els Troost; Marc Gewillig; Werner Budts
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

2.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions.

Authors:  Candice K Silversides; Omid Salehian; Erwin Oechslin; Markus Schwerzmann; Isabelle Vonder Muhll; Paul Khairy; Eric Horlick; Mike Landzberg; Folkert Meijboom; Carole Warnes; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

3.  Cardiovascular magnetic resonance in pulmonary hypertension.

Authors:  William M Bradlow; J Simon R Gibbs; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2012-01-18       Impact factor: 5.364

Review 4.  Thromboembolic complications in adult congenital heart disease: the knowns and the unknowns.

Authors:  Magalie Ladouceur; Clément Karsenty; Victor Waldmann; Barbara Mulder; Sébastien Hascoet
Journal:  Clin Res Cardiol       Date:  2020-10-09       Impact factor: 5.460

Review 5.  Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

Authors:  Nazzareno Galie; Alessandra Manes; Massimiliano Palazzini; Luca Negro; Alessandro Marinelli; Simona Gambetti; Elisabetta Mariucci; Andrea Donti; Angelo Branzi; Fernando M Picchio
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 6.  Adult congenital heart disease with pulmonary arterial hypertension: mechanisms and management.

Authors:  Michail Papamichalis; Andrew Xanthopoulos; Panagiotis Papamichalis; John Skoularigis; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

Review 7.  In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease.

Authors:  Yunshan Cao; Chao Geng; Yahong Li; Yan Zhang
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

8.  Pulmonary arterial thrombosis in a patient with an atrial septal defect and eisenmenger syndrome.

Authors:  Ching-Wei Lee; Shao-Sung Huang; Po-Hsun Huang
Journal:  Korean Circ J       Date:  2012-11-28       Impact factor: 3.243

9.  The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects.

Authors:  Erwin Oechslin; Siegrun Mebus; Ingram Schulze-Neick; Koichiro Niwa; Pedro T Trindade; Andreas Eicken; Alfred Hager; Irene Lang; John Hess; Harald Kaemmerer
Journal:  Curr Cardiol Rev       Date:  2010-11

10.  A Mock Circulatory System Incorporating a Compliant 3D-Printed Anatomical Model to Investigate Pulmonary Hemodynamics.

Authors:  Paul G M Knoops; Giovanni Biglino; Alun D Hughes; Kim H Parker; Linzhang Xu; Silvia Schievano; Ryo Torii
Journal:  Artif Organs       Date:  2016-12-07       Impact factor: 3.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.